NephroDI Therapeutics
nephrodi.com
Actively hiring
Rare Disease Therapeutics
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
2
Xontogeny, Sound Bioventures
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 10%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Xontogeny 
Sound Bioventures Similar startupsby what they do, their industry and backers
Surf Bio is leveraging a novel biotechnology platform to develop enhanced therapeutic solutions for Diabetes, Oncology, HIV, COVID-19, and…
Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high…
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
Forge Biologics is accelerating gene therapy manufacturing: high-yield AAV manufacturing, a world-class cGMP facility, and seamless support.
Valink is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.
ITsavvy provides best-in-class IT solutions, so you can focus on what’s most mission-critical for your business. See the ITsavvy difference…
Overview
About Us NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs.